Bartels Peter, Behnke Kerstin, Michels Guido, Groner Ferdi, Schneider Toni, Henry Margit, Barrett Paula Q, Kang Ho-Won, Lee Jung-Ha, Wiesen Martin H J, Matthes Jan, Herzig Stefan
Department of Pharmacology, University of Cologne, 50931 Koeln, Germany.
Cell Calcium. 2009 Oct;46(4):293-302. doi: 10.1016/j.ceca.2009.09.002. Epub 2009 Sep 26.
We investigated the biophysical mechanism of inhibition of recombinant T-type calcium channels Ca(V)3.1 and Ca(V)3.2 by nitrous oxide (N(2)O). To identify functionally important channel structures, chimeras with reciprocal exchange of the N-terminal domains I and II and C-terminal domains III and IV were examined. In whole-cell recordings N(2)O significantly inhibited Ca(V)3.2, and - less pronounced - Ca(V)3.1. A Ca(V)3.2-prevalent inhibition of peak currents was also detected in cell-attached multi-channel patches. In cell-attached patches containing < or = 3 channels N(2)O reduced average peak current of Ca(V)3.2 by decreasing open probability and open time duration. Effects on Ca(V)3.1 were smaller and mediated by a reduced fraction of sweeps containing channel activity. Without drug, single Ca(V)3.1 channels were significantly less active than Ca(V)3.2. Chimeras revealed that domains III and IV control basal gating properties. Domains I and II, in particular a histidine residue within Ca(V)3.2 (H191), are responsible for the subtype-prevalent N(2)O inhibition. Our study demonstrates the biophysical (open times, open probability) and structural (domains I and II) basis of action of N(2)O on Ca(V)3.2. Such a fingerprint of single channels can help identifying the molecular nature of native channels. This is exemplified by a characterization of single channels expressed in human hMTC cells as functional homologues of recombinant Ca(V)3.1.
我们研究了一氧化二氮(N₂O)对重组T型钙通道Ca(V)3.1和Ca(V)3.2的抑制作用的生物物理机制。为了确定功能上重要的通道结构,我们检测了N端结构域I和II以及C端结构域III和IV相互交换的嵌合体。在全细胞记录中,N₂O显著抑制Ca(V)3.2,对Ca(V)3.1的抑制作用较弱。在细胞贴附式多通道膜片中也检测到了Ca(V)3.2对峰值电流的优势抑制作用。在含有≤3个通道的细胞贴附式膜片中,N₂O通过降低开放概率和开放持续时间来降低Ca(V)3.2的平均峰值电流。对Ca(V)3.1的影响较小,是由包含通道活性的扫描比例降低介导的。在无药物情况下,单个Ca(V)3.1通道的活性明显低于Ca(V)3.2。嵌合体显示结构域III和IV控制基础门控特性。结构域I和II,特别是Ca(V)3.2内的一个组氨酸残基(H191),是亚型优势N₂O抑制作用的原因。我们的研究证明了N₂O对Ca(V)3.2作用的生物物理(开放时间、开放概率)和结构(结构域I和II)基础。单通道的这种特征有助于确定天然通道的分子性质。这在将人hMTC细胞中表达的单通道表征为重组Ca(V)3.1的功能同源物中得到了体现。